Aurobindo Pharma Q1 Results: Profit down 32% YoY to Rs 520.5 crore
The company's focus on the development of specialty products pipeline will establish new avenues to grow the business in future and along with that Aurobindo's aim to drive sustained improvement in profitability through newer avenues will enhance improved profitability over medium to long term, Reddy further said.